Abstract
Adenocarcinomas of the jejunum and ileum are rare gastrointestinal malignancies. Because few large published experiences exist, we reviewed patients with jejunal and ileal adenocarcinoma treated at our institution over the last 25 years. Between January 1976 and December 2001, 77 patients had an operation for a jejunal or ileal adenocarcinoma. Records were retrospectively reviewed for patient, tumor, and treatment variables. Factors affecting disease recurrence and patient survival were investigated. Fifty-two of the adenocarcinomas (67%) occurred in the jejunum and 25 occured in the ileum (33%). Mean patient age was 63 ±14 years. Segmental bowel resection was performed in 50 patients (65%) with curative intent. Palliative operative procedures including resection or bypass were performed in 27 patients (35%). One (1%) patient had stage I, 18 (23%) stage II, 19 (25%) stage III, and 39 (51%) stage IV adenocarcinoma at diagnosis. Postoperatively, 12 patients had palliative and 18 adjuvant chemotherapy (n 5 30), radiation therapy (n = 1), or combination treatment (n = 7). Median patient survival was 19 months. Sixty-six percent of patients who had a curative operation had a tumor relapse. Tumor stage had a highly significant effect (P < 0.0001) on median survival (72 months for stage I and II, 30 months for stage III, and 9 months for stage IV disease). In multivariate analysis of patients having curative treatment, tumor recurrence (P < 0.0001), stage (P < 0.0002), and weight loss (P < 0.001) were significant negative prognostic indicators. Most patients with adenocarcinoma of the jejunum or ileum present with advanced disease. Tumor stage, disease recurrence, and weight loss predicted patient outcome following a curative operation. Early recognition of these tumors requires a high index of suspicion.
References
Zollinger RM Jr. Primary neoplasms of the small intestine. Am J Surg 1986;151:654–658.
Ashley SW, Wells SA Jr. Tumors of the small intestine. Semin Oncol 1988;15:116–128.
Frost DB, Mercado PD, Tyrell JS. Small bowel cancer: A 30-year review. Ann Surg Oncol 1994;1:290–295.
Cunningham JD, Aleali RBA, Aleali M, Brower ST, Aufses AH. Malignant small bowel neoplasms: Histopathologic determinants of recurrence and survival. Ann Surg 1997;225(3):300–306.
North JH, Pack MS. Malignant tumors of the small intestine: A review of 144 cases. Am Surg 2000;66(1):46–51.
Talamonti MS, Goetz LH, Sambasiva R, Joehl RJ. Primary cancers of the small bowel. Arch Surg 2002;137:564–571.
Ito H, Perez A, Brooks DC, Osteen RT, Zinner MJ, Moore FD Jr, Ashley SW, Whang EE. Surgical treatment of small bowel cancer: A 20-year single institution experience. J Gastrointest Surg 2003;7:925–930.
Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481.
Peto R, Peto J. Asymptotically efficient rank invariant procedures. J R Stat Soc Ser A 1972;135:185–207.
Cox DR. Regression models and life-tables (with discussion). J R Stat Soc Ser B 1972;34:187–220.
Greene FL, Page DL, Fleming ID, et al., eds. Small intestine. In AJCC Cancer Staging Manual, 6th ed. New York: Springer Verlag, 2003, pp 107–112.
Bauer RL, Palmer ML, Bauer AM, Nava HR, Douglass HO. Adenocarcinoma of the small intestine: 21-year review of diagnosis, treatment and prognosis. Ann Surg Oncol 1994; 1(3):183–188.
Veyrieres M, Baillet P, Hay JM, Fingerhut A, Bouillot JL, Julien M. Am J Surg 1997;173:237–239.
Abrahams NA, Halverson A, Fazio VW, Rybicki LA, Goldblum JR. Adenocarcinoma of the small bowel: A study of 37 cases with emphasis on histologic prognostic factors. Dis Colon Rectum 2002;45(11):1496–1502.
Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel. Presentation, prognostic factors, and outcome of 217 patients. Cancer 2004;101:518–526.
Gill SS, Heuman DM, Mihas AA. Small intestinal neoplasms. J Clin Gastroenterol 2001;33(4):267–282.
Ge Z, Hu Y, Xiao S. Capsule endoscopy and push enteroscopy in the diagnosis of obscure gastrointestinal bleeding. Chin Med J 2004;117(7):1045–1049.
Bakeen FG, Murr MM, Sarr MG, Thompson GB, Farnell MB, Nagorney DM, Farley DR, van Heerden J, Wiersema LM, Schleck CD, Donohue JH. What prognostic factors are important in duodenal adenocarcinoma. Arch Surg 2000;135(6):635–642.
Glotzer DJ. The risk of cancer in Crohn’s disease. Gastroenterology 1985;89:438–441.
Solem CA, Harmsen WS, Zinsmeister AR, Loftus EV Jr. Small intestinal adenocarcinoma in Crohn’s disease: A case-control study. Inflamm Bowel Dis 2004;10(1):32–35.
Howe JR, Karnell LH, Menck HR, Scott-Corner C. Adenocarcinoma of the small bowel: Review of the National Cancer Data Base. Cancer 1999;86:2693–2706.
Polyzos A, Kouraklis G, Giannopoulos A, Bramis J, Delladetsima JK, Sfikakis PP. Irinotecan as salvage chemotherapy for advanced small bowel adenocarcinoma: A series of three patients. J Chemother 2003;15(5):503–506.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ugurlu, M.M., Asoglu, O., Potter, D.D. et al. Adenocarcinomas of the jejunum and ileum: A 25-year experience. J Gastrointest Surg 9, 1182–1188 (2005). https://doi.org/10.1016/j.gassur.2005.08.027
Issue Date:
DOI: https://doi.org/10.1016/j.gassur.2005.08.027